Meeting
2022 ASCO Genitourinary Cancers Symposium
Evolving real-world patterns of practice in metastatic castration-sensitive prostate cancer (mCSPC): The genitourinary research consortium (GURC) national multicenter cohort study.
Authors
Steven Yip
Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada
Steven Yip , Tamim Niazi , Sebastien J. Hotte , Luke Lavallee , Antonio Finelli , Anil Kapoor , Michael Paul Kolinsky , Michael Ong , Frederic Pouliot , Elie Antebi , Darrel Drachenberg , Geoffrey Gotto , Robert James Hamilton , Krista Noonan , Ricardo A. Rendon , Bobby Shayegan , Anousheh Zardan , Kim N. Chi , Fred Saad , Chris Morash
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 86)
DOI
10.1200/JCO.2022.40.6_suppl.086
Abstract #
86
Poster Bd #
E1
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Clinical and patient factors associated with treatment intensification for metastatic castration-sensitive prostate cancer.
First Author: Sreevalsa Appukkuttan
Poster
2023 ASCO Genitourinary Cancers Symposium
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer.
First Author: Geoffrey T. Gotto
Poster
2023 ASCO Genitourinary Cancers Symposium
Utilization of metastatic hormone sensitive prostate cancer (mHSPC) treatment in a community oncology practice setting.
First Author: Terri Conner
Poster
2022 ASCO Genitourinary Cancers Symposium
Underutilization of standard of care (SOC) treatment intensification in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) by specialty.
First Author: Umang Swami